Skip to main content
Theranostics logoLink to Theranostics
. 2022 Apr 26;12(8):3609. doi: 10.7150/thno.73630

Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy: Erratum

Jianmin Hu 1,2,3, Yueshuo Li 1,2,3, Hongde Li 1,2,3, Feng Shi 1,2,3, Longlong Xie 1,2,3, Lin Zhao 1,2,3, Min Tang 1,2,3,4, Xiangjian Luo 1,2,3,4, Weihua Jia 7, Jia Fan 8, Jian Zhou 8, Qiang Gao 8, Shuangjian Qiu 8, Weizhong Wu 8, Xin Zhang 9, Weihua Liao 10, Ann M Bode 11, Ya Cao 1,2,3,4,5,6,
PMCID: PMC9131263  PMID: 35664071

In the original publication, errors were found in Fig. 4H (right). The images were misassigned. We re-analyzed the raw data and correct the images. The correct figures are shown below. The authors confirm that these corrections do not change the result interpretation or conclusions of the article. The authors are sorry and sincerely apologize for any inconvenience or misunderstanding that may have caused.

Figure 4.

Figure 4

H (right) The expression of 8-OHdG and EAD was calculated based on LMP1 expression in NPC patients (***p < 0.001).


Articles from Theranostics are provided here courtesy of Ivyspring International Publisher

RESOURCES